Insider sale
DYNE THERAPEUTICS, INC.
$2.16M
102.97K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 102.97K shares of DYNE THERAPEUTICS, INC. valued at approximately $2.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001628280-26-046094
10% Owner
Since Sep 2020
102.97K
Shares to sell
$2.16M
Approx. market value
102.97K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
102.97KTotal acquired102.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 102.97K | — |
| Total | 102.97K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
102.97K
Market value
$2.16M
6/29/2026
Total
Units
102.97K
Value
$2.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/29/2026 | 102.97K | $2.16M | Nasdaq | Planned |
| Total | 102.97K | $2.16M | ||